N,N-Dibenzyl-2-chloroethanamine hydrochloride, 95.0%, 1g

1-Bromo-4-(2-fluoropropan-2-yl)benzene, 95.0%, 1g

ETHYL 2-AMINO-3-CYCLOBUTYLPROPANOATE HCL, 97.0%, 5g

Standard Abbe condenser 1.25 NA with holder for dark field stop and slides with phase contrast rings

8-Bromo-4-chloro-6-methylquinoline, 97%, 1g

Ethoxymalonic acid diethyl ester, 95.0%, 1g

2-Ethylhexyl-4-hydroxybenzoate, 98%, 25g

1,3-Dimethyl-1H-pyrazol-4-amine, 95.0%, 1g

(4-Oxocyclohexyl)acetic acid, 95.0%, 5g

3,4-Dichloro-1-(4-fluorophenyl)-1H-pyrrole-2,5-dione, 97%, 1g

3-(1-((Benzyloxy)carbonyl)piperidin-4-yl)-2-((tert-butoxycarbonyl)amino)propanoic acid, 95.0%, 5g

Ethanol, 2-[2-[2-[2-(aminooxy)ethoxy]ethoxy]ethoxy]-, 95%, 100mg

4-Bromo-1-ethyl-3-methyl-1H-pyrazole-5-carboxylic acid, 95.0%, 5g